Literature DB >> 17368307

The auditory cortex in schizophrenia.

Wei-Xing Shi1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17368307      PMCID： PMC1853248          DOI： 10.1016/j.biopsych.2007.02.007

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  11 in total

1.  Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits.

Authors:  Robert A Sweet; Sarah E Bergen; Zhuoxin Sun; Allan R Sampson; Joseph N Pierri; David A Lewis
Journal:  Biol Psychiatry       Date:  2004-06-15       Impact factor: 13.382

2.  Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia.

Authors:  Robert A Sweet; Joseph N Pierri; Sungyoung Auh; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2002-12-03       Impact factor: 7.853

3.  GABA neuronal subpopulations in cat primary auditory cortex: co-localization with calcium binding proteins.

Authors:  S H Hendry; E G Jones
Journal:  Brain Res       Date:  1991-03-08       Impact factor: 3.252

4.  The non-pyramidal cells in layer III of cat primary auditory cortex (AI).

Authors:  J A Winer
Journal:  J Comp Neurol       Date:  1984-11-10       Impact factor: 3.215

5.  Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia.

Authors:  Robert W McCarley; Dean F Salisbury; Yoshio Hirayasu; Deborah A Yurgelun-Todd; Mauricio Tohen; Carlos Zarate; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton
Journal:  Arch Gen Psychiatry       Date:  2002-04

6.  Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging.

Authors:  S S Shergill; M J Brammer; S C Williams; R M Murray; P K McGuire
Journal:  Arch Gen Psychiatry       Date:  2000-11

7.  Anatomical evidence of impaired feedforward auditory processing in schizophrenia.

Authors:  Robert A Sweet; Sarah E Bergen; Zhuoxin Sun; Michael J Marcsisin; Allan R Sampson; David A Lewis
Journal:  Biol Psychiatry       Date:  2006-11-21       Impact factor: 13.382

8.  Neuronal substrates of sensory gating within the human brain.

Authors:  Thomas Grunwald; Nashaat N Boutros; Nico Pezer; Joachim von Oertzen; Guillen Fernández; Carlo Schaller; Christian E Elger
Journal:  Biol Psychiatry       Date:  2003-03-15       Impact factor: 13.382

9.  Neuroanatomy of "hearing voices": a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia.

Authors:  Christian Gaser; Igor Nenadic; Hans-Peter Volz; Christian Büchel; Heinrich Sauer
Journal:  Cereb Cortex       Date:  2004-01       Impact factor: 5.357

10.  Morphology and spatial distribution of GABAergic neurons in cat primary auditory cortex (AI).

Authors:  J J Prieto; B A Peterson; J A Winer
Journal:  J Comp Neurol       Date:  1994-06-15       Impact factor: 3.215
View more
  3 in total

1.  Abnormal Grey Matter Arteriolar Cerebral Blood Volume in Schizophrenia Measured With 3D Inflow-Based Vascular-Space-Occupancy MRI at 7T.

Authors:  Jun Hua; Allison S Brandt; SeungWook Lee; Nicholas I S Blair; Yuankui Wu; Su Lui; Jaymin Patel; Andreia V Faria; Issel Anne L Lim; Paul G Unschuld; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

2.  Application of Mass Multivariate Analysis on Neuroimaging Data Sets for Precision Diagnostics of Depression.

Authors:  Rositsa Paunova; Sevdalina Kandilarova; Anna Todeva-Radneva; Adeliya Latypova; Ferath Kherif; Drozdstoy Stoyanov
Journal:  Diagnostics (Basel)       Date:  2022-02-12

3.  Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat.

Authors:  Christien Bowman; Ulrike Richter; Christopher R Jones; Claus Agerskov; Kjartan Frisch Herrik
Journal:  Front Psychiatry       Date:  2022-01-27       Impact factor: 4.157
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.